Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune activation in measles.

D E Griffin1, B J Ward, E Jauregui

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

The New England Journal of Medicine
|June 22, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Particle size as a driver of dewatering performance and its relationship to stabilization in fecal sludge.

Journal of environmental management·2022
Same author

Travel-acquired infections in Canada: CanTravNet 2011-2012.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

Immunogenicity in Protein and Peptide Based-Therapeutics: An Overview.

Current protein & peptide science·2017
Same author

Travellers and influenza: risks and prevention.

Journal of travel medicine·2017
Same author

Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.

Vaccine·2015
Same author

A new 5-alkylresorcinol glucoside derivative from Cybianthus magnus.

Natural product research·2015
Same journal

Sparganosis.

The New England journal of medicine·2026
Same journal

Caring for an Aging America - The Looming Crisis of the Long-Term-Care Workforce.

The New England journal of medicine·2026
Same journal

For Those Left Behind.

The New England journal of medicine·2026
Same journal

Colliding Forces - The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply.

The New England journal of medicine·2026
Same journal

Mandated State-Level Surveillance of Assisted Reproductive Technology - An Emerging Threat in the United States.

The New England journal of medicine·2026
Same journal

Ebola at 50 - Lessons for Outbreak Response and Preparedness.

The New England journal of medicine·2026
See all related articles

Measles triggers immune activation, with soluble interleukin-2 receptor indicating early proliferation and soluble CD8 signaling the effector phase. These immune markers help differentiate measles complications like encephalomyelitis.

Area of Science:

  • Immunology
  • Virology
  • Neurology

Background:

  • Measles infection is linked to immune dysregulation, potentially causing secondary infections or autoimmune encephalomyelitis.
  • An effective measles virus-specific immune response concurrently develops during measles infection.

Purpose of the Study:

  • To investigate the relationship between immune activation and measles, including its complications.
  • To analyze spontaneous mononuclear cell proliferation and levels of soluble interleukin-2 receptor and CD8 T-cell antigens in measles patients.

Main Methods:

  • Studied 126 patients with complicated or uncomplicated measles at various disease stages.
  • Measured spontaneous proliferation of blood mononuclear cells.
  • Quantified circulating levels of soluble interleukin-2 receptor and CD8 T-cell antigens.

Related Experiment Videos

Main Results:

  • Mononuclear cell proliferation and soluble CD8 levels were elevated during the rash phase.
  • Soluble interleukin-2 receptor levels were elevated before the rash and remained high for weeks, indicating early immune activation.
  • Lower soluble interleukin-2 receptor levels were observed in patients with encephalomyelitis, while soluble CD8 was increased in cerebrospinal fluid during encephalomyelitis.

Conclusions:

  • The proliferative immune response (indicated by soluble interleukin-2 receptor) begins before the rash and continues post-illness in uncomplicated measles.
  • The effector immune response (indicated by soluble CD8) coincides with the rash and occurs in the central nervous system during encephalomyelitis.
  • Immune marker dynamics aid in understanding measles pathogenesis and its neurological complications.